Thermo Fisher Scientific Other Regions — Consolidated revenues increased by 4.5% to $415.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 4.5%, from $397.00M to $415.00M. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates successful market penetration or growth in secondary international territories, while a decrease may signal regional economic headwinds or a shift in global sales strategy.
This metric represents the total net sales generated by the company from all geographical territories not explicitly rep...
Peers often report this as 'Rest of World' or 'Other International' revenue, which is typically compared against total international revenue growth rates to identify regional performance disparities.
tmo_segment_other_regions_consolidated_revenues| Q2 '21 | Q1 '22 | Q2 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q3 '24 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|
| Value | $300.00M | $381.00M | $345.00M | $369.75M | $369.75M | $369.75M | $369.75M | $397.00M | $415.00M |
| QoQ Change | — | +27.0% | -9.4% | +7.2% | +0.0% | +0.0% | +0.0% | +7.4% | +4.5% |
| YoY Change | — | — | +15.0% | -3.0% | +7.2% | — | — | +7.4% | +4.5% |
We use cookies for analytics. See our Privacy and Cookie Policy.